Eurofarma Laboratorios S.a.
Clinical trials sponsored by Eurofarma Laboratorios S.a., explained in plain language.
-
New weight loss pill aims to beat current drugs
Disease control TerminatedThis study aimed to test the safety and effectiveness of a new combination weight loss pill (sibutramine and topiramate) in overweight or obese adults, some of whom had other health conditions like high blood pressure. It compared the new pill to a dummy pill (placebo) and to one…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Apr 02, 2026 05:26 UTC
-
Two-in-One diabetes pill trial halted before launch
Disease control TerminatedThis study aimed to test if a single pill containing two common diabetes medications works better for blood sugar control than taking the medications separately. It was designed for adults with type 2 diabetes who were already taking metformin. The trial was withdrawn by the spon…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Diabetes drug duo trial halted before starting
Disease control TerminatedThis study aimed to test if using two diabetes drugs together works better than using either one alone for people whose blood sugar is still too high on metformin. It planned to enroll adults with type 2 diabetes to compare the combination's effectiveness and safety over 16 weeks…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New asthma inhaler put to the test
Disease control TerminatedThis study aimed to see if a new, lower-dose asthma inhaler works as well as a standard one for controlling moderate asthma. It planned to enroll people aged 12 and older with moderate asthma. The main goal was to compare how well the two inhalers helped patients breathe over a 1…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New combo pill aims to beat standard allergy drug for stuffy noses
Symptom relief TerminatedThis study aimed to test if a new pill combining two medicines (levocetirizine and pseudoephedrine) works better than a standard allergy pill (levocetirizine alone) to relieve symptoms of allergic rhinitis, especially a stuffy nose. It was planned for people aged 12 to 65 with se…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Hoped-for nerve pain pill trial cancelled before starting
Symptom relief TerminatedThis was a large, late-stage study that planned to test if a new drug called N0750 could relieve pain better than two commonly used medications (Cymbalta and Lyrica) in people with painful diabetic neuropathy. The trial was designed to be very thorough, using placebos and keeping…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Mar 10, 2026 12:53 UTC